Medical Policy


Subject:Behavioral Health Treatments for Pervasive Developmental Disorders
Policy #:  BEH.00004Current Effective Date:  01/01/2013
Status:ReviewedLast Review Date:  08/09/2012

Description/Scope

This document addresses pharmacotherapeutic and behavioral health-related treatments and therapies used to treat Pervasive Developmental Disorders (PDD).  PDD's include:

Note: For information on other services that may be provided for pervasive developmental disorders, see

Note: This document does not address Applied Behavior Analysis or Applied Behavioral Analysis (ABA) therapy.  ABA therapy may not be a covered benefit under the health benefit plan.  By way of example only, many benefit contracts only provide benefits for services rendered by licensed clinicians, and many benefit contracts exclude coverage for services that are educational in nature.

Position Statement

Medically Necessary:

Behavior modification, family therapy, or other forms of psychotherapy, that are clinically appropriate in terms of type, frequency, extent, site and duration, for management of behavioral symptoms related to autism, Asperger's syndrome, Rett syndrome, childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (NOS) are considered medically necessary when required for the management of behaviors, especially where there is the potential for individuals to harm themselves or others, or when such treatment would otherwise be considered medically necessary.

Psycho-pharmacotherapy for management of target symptoms or co-morbidities related to autism, Asperger's syndrome, Rett syndrome, childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (NOS) is considered medically necessary.    

Investigational and Not Medically Necessary: 

The following treatments or therapies are considered investigational and not medically necessary for the treatment of autism, Asperger's syndrome, Rett syndrome, childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (NOS):

Rationale

Autism, Asperger's syndrome, Rett syndrome, childhood disintegrative disorder, and pervasive developmental disorder Not Otherwise Specified (NOS) are complex and multifaceted conditions for which there is no known specific etiology, although there is evidence of a genetic etiology in autism and Rett syndrome. The impairments of these conditions are generally severe, and, given the uncertainty around the cause(s) of these disorders, treatments are not directed at the core pathology, but at the co-morbid medical and behavioral conditions. The medically necessary treatments have validity as components of treating the co-morbidities, and are evidence-based. Those treatments deemed Investigational and Not Medically Necessary lack sufficient evidence as to their effectiveness, safety, relevance, and/or reliability in improving the pathological manifestations of autism, Asperger's syndrome, Rett syndrome and pervasive developmental disorders.

Background/Overview

Description of Pervasive Developmental Disorders (PDD)

The term pervasive developmental disorders (PDD) refers to a group of disorders characterized by delays in the development of socialization and communication skills which are often accompanied by cognitive and language delays.  Parents may note symptoms as early as infancy, and the typical age of onset is before 3 years of age. Symptoms may include problems with using and understanding language; difficulty relating to or reciprocating with people, objects, and events; lack of mutual gaze or inability to attend events conjointly; unusual play with toys and other objects; difficulty with changes in routine or familiar surroundings, and repetitive body movements or behavior patterns. Autism is the most characteristic and best studied PDD. Other types of PDD include Asperger's syndrome, Rett syndrome, and childhood disintegrative disorder (CDD). CDD is a condition similar to autism, but with onset after the age of 3 and is characterized by a period of clearly normal development prior to onset of severe developmental regression and onset of behaviors suggestive of autism. Children with PDD vary widely in abilities, intelligence, and behaviors. Some children do not speak at all, others speak in limited phrases or conversations, and some have relatively normal language development.  Repetitive play skills, resistance to change in routine and inability to share experiences with others, and limited social and motor skills are generally evident.  Unusual responses to sensory information, such as loud noises and lights, are also common.

Children can exhibit unusual behaviors occasionally, or seem shy around others sometimes - without having a PDD.  What sets children with PDDs apart is the consistency of their unusual behaviors.  Symptoms of the disorder have to be present in all settings - not just at home or at school - and over considerable periods of time.  With PDD, there is a lack of social interaction, impairment in nonverbal behaviors, and a failure to develop normal peer relations.  A child with a PDD tends to ignore facial expressions and may not look at others; other children may fail to respect interpersonal boundaries and come too close and stare fixedly at another person.

Description of Autism

Autism is a complex developmental disorder that affects the brain's development in the areas of social interactions and communication.  Symptoms appear in the first 3 years of life, although diagnosis frequently is not made until much later.  Symptoms of autism vary significantly in severity, but there are several core features to the condition, including gross and sustained impairment in reciprocal social interactions, impaired verbal and nonverbal communication, and restricted or repetitive patterns of behavior.

Most parents of autistic children suspect that something is wrong by the time the child is 18 months old and seek help by the time the child is 2.  However, some children with autism appear normal before age 1 or 2 and then suddenly "regress" and lose language or social skills they had previously gained.  This is called the regressive or disintegrative type of autism and is seen in a minority of cases.

People with autism may perform repeated body movements, show unusual attachments to objects or have unusual distress when routines are changed.  Individuals may also experience sensitivities in the senses of sight, hearing, touch, smell, or taste.  Such children, for example, will refuse to wear "itchy" clothes and become unduly distressed if forced because of the hyper-sensitivity of their skin or hyper-reactivity to other sensations. This disorder often manifests a co-existing expressive/receptive language disorder and mental retardation.

The exact causes of autism are unknown, although genetic factors are strongly implicated.  A recent study released by the Center for Disease Control and Prevention (2012) indicates that the incidence of Autism Spectrum Disorders was as high as 1 in 88. 

Description of Asperger's Syndrome

Like autism, Asperger's syndrome (AS) is a developmental disorder characterized by impairment in communication skills, as well as repetitive or restrictive patterns of thought and behavior, but without significant language or cognitive delay.  Parents usually sense there is something unusual about a child with AS by the time of his or her third birthday, but typically clinical concern does not arise until the time the child enters a preschool setting.  Unlike children with autism, children with AS retain their early language skills, although their presentation is usually abnormal.  Higher cognitive function tends to be preserved in individuals with AS.  Motor development delays – crawling or walking late, clumsiness – are sometimes the first indicators of the disorder. 

In addition to the preservation of some aspects of language functioning, another of the most distinguishing symptoms of AS is a child's obsessive interest in a single object or topic to the exclusion of any other.  Children with AS want to know everything about their topic of interest and their conversations with others will be about little else.  Their expertise in some areas of interest, high level of vocabulary, and formal speech patterns make them seem like "little professors."  Other characteristics of AS include repetitive routines or rituals; peculiarities in speech and language; socially and emotionally inappropriate behavior and the inability to interact successfully with peers; problems with non-verbal communication; and clumsy and uncoordinated motor movements.

Children with AS usually have a history of developmental delays in motor skills such as pedaling a bike, catching a ball, or climbing outdoor play equipment.   They are often awkward and poorly coordinated with a walk that can appear either stilted or bouncy. 

The incidence of AS is not well established.  Boys are three to four times more likely than girls to have AS.      

Although diagnosed mainly in children, AS is being increasingly diagnosed in adults who seek medical help for mental health conditions such as depression, obsessive-compulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD).  They should have a childhood history consistent with the diagnosis.  No studies have yet been conducted to determine the incidence of AS in adult populations.

Description of Rett Syndrome

Rett syndrome is a disorder of the nervous system that leads to regression in development, especially in the areas of expressive language and hand use.  In most cases, it is caused by a genetic mutation.  It occurs almost exclusively in girls and may be misdiagnosed as autism or cerebral palsy.

Seventy-five percent of Rett syndrome cases have been linked to a specific genetic mutation on the x chromosome.  This gene contains instructions for creating methyl-CpG-binding protein 2 (MeCP2), which regulates the manufacture of various other proteins.  Mutations in the MeCP2 gene cause these other proteins to be produced incorrectly, which damages the maturing brain.  Studies link mutations in this gene.  Most cases of the mutation arise spontaneously without any traceable cause.  However, there also seem to be some clusters within families and certain geographic regions, for example Norway, Sweden, and Northern Italy.

A child affected with Rett syndrome normally follows a standard developmental path for the first 5 months of life.  After that time development in communication skills and motor movement in the hands seems to stagnate or regress.  After a short period stereotyped hand movements, gait disturbances, and slowing of the rate of head growth become apparent.  Other problems may also be associated with Rett syndrome, including seizures, disorganized breathing patterns while awake and apraxia/dyspraxia (the inability to program the body to perform motor movements).  Apraxia/dyspraxia is a key symptom of Rett syndrome and it results in significant functional impairment, interfering with body movement, including eye gaze and speech.

Description of Childhood Disintegrative Disorder

The essential feature of childhood disintegrative disorder (CDD) is a marked regression in multiple areas of functioning following a period of at least 2 years of apparently normal development.  Apparently normal development is reflected in age-appropriate verbal and nonverbal communication, social relationships, play, and adaptive behavior.  After the first 2 years of life (but before age 10 years), the child has a clinically significant loss of previously acquired skills in at least two of the following areas:  expressive or receptive language, social skills or adaptive behavior, bowel or bladder control, play, or motor skills.  Individuals with this disorder exhibit the social and communicative deficits and behavioral features generally observed in autism.  There is qualitative impairment in social interaction and in communication, and restricted, repetitive, and stereotyped patterns of behavior, interests, and activities.  The disturbance is not better accounted for by another specific pervasive developmental disorder or by schizophrenia.

Description of Treatments

The diagnosis of PDD can be complex and difficult due to the diversity of the presentation of symptoms and their severity.  Due to the multitude of possible causes, and potential confusion with other conditions, many tests exist that may or may not be appropriate.  It is vital that parents of children suspected of having a PDD seek early diagnosis and care for their child to increase any potential benefits of treatment.

The treatment of PDDs may take many different approaches, focusing on one of more aspects of the condition being treated. There is no single treatment that has consistently demonstrated benefit at the core symptoms of these disorders. Family therapy is generally supported as a valuable treatment because it offers emotional support and guidance to parents who will contend with a myriad of services to assist their child. Individual therapy using social story technique and behavioral cue coaching are very useful for the older child/adolescent with Asperger's syndrome and can make a difference in that child's acceptance by others.

Definitions

Asperger's syndrome: A developmental disorder that affects the parts of the brain that control social interaction and communications.

Autism: A developmental disorder that affects the parts of the brain that control social interaction and verbal and non-verbal communication.

Behavior modification: A therapy type that is designed to create new behavior patterns in people through intensive and frequent feedback using a reward, non-reward system.

Childhood disintegrative disorder:  A developmental disorder characterized by marked regression in multiple areas of functioning following a period of at least 2 years of apparently normal development.

Pervasive developmental disorder (PDD): A group of developmental disorders, including autism, Asperger's syndrome, and Rett syndrome, that are characterized by dysfunction in parts of the brain controlling social interaction and communications, among others.

Rett syndrome: A developmental disorder that affects the parts of the brain that control social interaction, communications, and motor function.

Coding

The following codes for treatments and procedures applicable to this document are included below for informational purposes.  A draft of future ICD-10 Coding (effective 10/01/2014) related to this document, as it might look today, is included below for your reference.  Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy.  Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.

When services are Medically Necessary: 

CPT 
 Services may include, but are not limited to, the following:
90785Interactive complexity
90832-90838Psychotherapy services [includes codes 90832, 90833, 90834, 90836, 90837, 90838]
90846-90853Family and group psychotherapy services [includes codes 90846, 90847, 90849, 90853]
90863Pharmacologic management, including prescription and review of medication, when performed with psychotherapy services
  
HCPCS 
G0410Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes
G0411Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes
  
ICD-9 Diagnosis 
299.00-299.01Autistic disorder
299.10-299.11Childhood disintegrative disorder
299.80-299.81Other specified pervasive developmental disorders (Asperger's disorder)
299.90-299.91Unspecified pervasive developmental disorder
330.8Other specified cerebral degenerations in childhood (Rett's syndrome)
  
ICD-10 DiagnosisICD-10-CM draft codes; effective 10/01/2014:
F84.0-F84.9Pervasive developmental disorders

When services are Investigational and Not Medically Necessary:
For the following procedure and diagnosis codes; or when the code describes a procedure indicated in the Position Statement section as investigational and not medically necessary.

HCPCS 
G0176Activity therapy, such as music, dance, art or play therapies, not for recreation, related to the care and treatment of patient's disabling mental health problems, per session
  
ICD-9 Diagnosis 
299.00-299.01Autistic disorder
299.10-299.11Childhood disintegrative disorder
299.80-299.81Other specified pervasive developmental disorders (Asperger's disorder)
299.90-299.91Unspecified pervasive developmental disorder
330.8Other specified cerebral degenerations in childhood (Rett's syndrome)
  
ICD-10 DiagnosisICD-10-CM draft codes; effective 10/01/2014:
F84.0-F84.9Pervasive developmental disorders
  
References

Peer Reviewed Publications:

  1. Dawson G, Rogers S, Munson J, et al.  Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010; 125(1):e17-e23.
  2. Eldevik S, Eikeseth S, Jahr E, Smith T. Effects of low-intensity behavioral treatment for children with autism and mental retardation. J Autism Dev Disord. 2006; 36(2):211-224.
  3. Gutstein, SE, Burgess AF, Montfort K.  Evaluation of the relationship development intervention program.  Autism. 2007; 11(5):397-411.
  4. Howard JS, Sparkman CR, Cohen HG, et al. Comparison of intensive behavior analytic and eclectic treatments for young children with autism. Res Dev Disabil. 2005; 26(4):359-383.
  5. Sheinkopf SJ, Siegel B.  Home-based behavioral treatment of young children with autism. J Autism Dev Disord. 1998; 28(1):15-23.

Government Agency, Medical Society, and Other Authoritative Publications:

  1. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. Academy of Child and Adolescent Psychiatry Working group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999; 38(Supp 12):32S-54S.
  2. American Academy of Child and Adolescent Psychiatry. Policy Statement- Secretin in the Treatment of Autism. June 15, 2002. Available at: http://www.aacap.org/cs/root/policy_statements/secretin_in_the_treatment_of_autism. Accessed on May 30, 2012.
  3. American Academy of Pediatrics; Committee on Children with Disabilities. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics. 2001; 107(5):1221-1226.
  4. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ. December 18, 2009; 58(SS10):1-20.
  5. Canadian Pediatric Society Position Statement, Early intervention for children with autism, published in Pediatric Child Health. 2004; 9(4):267-277.
  6. Centers for Disease Control and prevention. Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008.  March 20, 2012.  Available at: http://www.cdc.gov/mmwr/pdf/ss/ss6103.pdf.  Accessed on May 31, 2012
  7. Diggle TTJ, McConachie HHR. Parent-mediated early intervention for young children with autism spectrum disorder. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003496.
  8. Greenspan SI, Brazelton TB, Cordero J, et al. Guidelines for early identification, screening, and clinical management of children with autism spectrum disorders.  Pediatrics. 2008; 121(4):828-830.
  9. McPheeters ML, Warren Z, Sathe N, et al. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics. 2011; 127(5):e1312-1321.
  10. Myer SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007; 120(5):1162-1182.  Available at:  http://www.pediatrics.org/cgi/content/full/120/5/1162.  Accessed on May 30, 2012.
Web Sites for Additional Information
  1. International Rett Syndrome Association. Available at: http://www.rettsyndrome.org. Accessed on May 30, 2012.
  2. National Institute of Neurological Disorders and Stroke. Asperger's Syndrome - Short Summary. Available at: http://www.ninds.nih.gov/disorders/Asperger/Asperger.htm. Accessed on May 30, 2012.
  3. National Institute of Neurological Disorders and Stroke. Pervasive Developmental Disorders Available at: http://www.ninds.nih.gov/disorders/pdd/pdd.htm.  Accessed on May 30, 2012.
  4. National Library of Medicine. Medical Encyclopedia, Autism. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/001526.htm. Accessed on May 30, 2012.
  5. National Library of Medicine. Medical Encyclopedia, Rett Syndrome. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/001536.htm. Accessed on May 30, 2012.
  6. The Nemours Foundation. Pervasive Developmental Disorders. Available at: http://kidshealth.org/parent/medical/learning/pervasive_develop_disorders.html. Accessed on May 30, 2012.
Index

Discrete Trial Training
Pet therapy

Document History
StatusDateAction
 01/01/2013Updated Coding section with 01/01/2013 CPT changes; removed codes 90804, 90805, 90806, 90807, 90808, 90809, 90810, 90811, 90812, 90813, 90814, 90815, 90816, 90817, 90818, 90819, 90821, 90822, 90823, 90824, 90826, 90827, 90828, 90829, 90857, 90862 deleted 12/31/2012.
Reviewed08/09/2012Medical Policy & Technology Assessment Committee (MPTAC) review
Reviewed08/03/2012Behavioral Health Subcommittee review.  No change to position statement.  Updated Reference section.  Updated Coding section; removed ICD-9 procedure codes (not applicable).
Reviewed08/18/2011Medical Policy & Technology Assessment Committee (MPTAC) review
Reviewed08/12/2011Behavioral Health Subcommittee review.  No change to position statement.  Updated Reference section.
Revised08/19/2010MPTAC review.  Simplified document title. Removed all non-behavioral health-related treatments from BEH.00004 and moved them to new document: MED.00107. Updated Rationale, Background, Coding and Definitions sections.
Reviewed05/13/2010MPTAC review.  No change to position statement.  Updated Coding and Reference sections.
Reviewed02/21/2009MPTAC review.  No change to position statement.  Updated Reference section.
 01/01/2009Updated Coding section with 01/01/2009 HCPCS changes; removed Q4097 deleted 12/31/2008.
Revised07/25/2008MPTAC review. Clarified position statements in the medically necessary section. Added use of hyperbaric oxygen therapy and chelation therapy to investigational and not medically necessary position statement. Deleted Lovaas therapy from investigational and not medically necessary position statement.  Updated Rationale, Coding, and Reference sections.    
 01/01/2008Updated Coding section with 01/01/2008 HCPCS changes; removed HCPCS J1567, Q4087, Q4088, Q4091, Q4092 deleted 12/31/2007.  The phrase "investigational/not medically necessary" was clarified to read "investigational and not medically necessary."  This change was approved at the November 29, 2007 MPTAC meeting.
Revised08/23/2007MPTAC review. Minor wording revision to position statement for "Interventions to improve verbal and nonverbal communication skills." Updated Reference section.
 07/01/2007Updated Coding section with 07/01/2007 HCPCS changes; removed HCPCS J1563, J1564, Q9941, Q9942, Q9943, Q9944 deleted 12/31/2005.
Revised09/14/2006MPTAC review. Revised rationale; updated references.
Reviewed03/23/2006MPTAC review.
New12/01/2005MPTAC initial document development.